XM does not provide services to residents of the United States of America.

Technical Analysis – ETHUSD heads towards 2024 highs on ETF approval hopes



  • ETHUSD set to notch up a second straight day of sharp gains

  • Hopes of spot ether ETF trigger broad-based crypto rally

  • But danger that upswing is becoming overstretched

 

ETHUSD (ether) has charged through its 50-day simple average (SMA) to make a fresh bid for the March peak of 4,093.70, which was a more than two-year high. The surge comes on renewed speculation that an approval by the US Securities and Exchange Commission for a spot ether ETF is imminent.

The momentum indicators point to a strong bullish bias in the near term, but there is a growing risk of a negative correction. Both the RSI and the stochastics have just entered their respective overbought territories.

If ETHUSD extends its rally, the March high of 4093.70 is the first point of call, after which attention would turn to the 4,400.00 zone, which was a frequently tested region from October to December 2021. Breaking above 4,400.00 could pave the way for the all-time high of 4,867.60.

However, should the price go into reverse, there could be some support at the 38.2% Fibonacci retracement of the January-March upleg at 3,356.86. Further down, the 50-day SMA could attempt to halt the decline around 3,161.50. But a more crucial support is the 61.8% Fibonacci of 2,901.64. A breach of this level would shift the risks to the downside.

In brief, there could be some further limited gains for ETHUSD in the short term before the rally pauses for breath. But the price needs to surpass the March top to put the uptrend on a more sustainable footing, whereas a drop below the 61.8% Fibo would invite the bears.

Related Assets


Latest News


Spotlight on kiwi as RBNZ decides on rates next week – Preview

N

Bitcoin plummets to a 4-month low, diverging from stocks – Crypto News


Technical Analysis – AUDUSD records new 6-month high

A

Week Ahead – Round two of French elections, Powell testimony and US CPI

U
E
G
N

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.